Human Resource & Employment Services

20-WEEKS OF RESISTANCE PENETRATED BULLISH SENTIMENT ESCALATING (a danger)*... but OVERBOUGHTNESS (MCCLELLAN OSCILLATOR) IN NEUTRAL STILL MORE TO GO... METHINKS SHORT SQUEEZE COULD FIRE Ok, so we have now broke-out through the significant overhead resistance in the major indexes as I predicted and...

TeamStaff, Inc. (Nasdaq: TSTF) announced today the appointment of Mr. John E. Kahn as Chief Financial Officer. Mr. Kahn brings over 25 years of financial experience to TeamStaff and will be responsible for all elements of accounting and finance for the organization. The company's executive search...

Recently, Optimer Pharmaceuticals, Inc. (OPTR) announced the submission of the first section of a rolling New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its anti-infective candidate fidaxomicin. Optimer is seeking marketing approval of the candidate for treating...

Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that it has submitted the first section of a rolling New Drug Application (NDA) to the U.S. Food and Drug Administration for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI....

Military interest in Oxygen Biotherapeutics' (OXBT) Oxycyte continues to be a strong driver for clinical development. The company's phase 2b clinical trial studying Oxycyte for the treatment of traumatic brain injury (TBI), which has been enrolling at sites in Switzerland and Israel, has recently...

Quote of the day “I am a huge Bull on this country. We will not have a double-dip recession. I see our businesses coming back almost across the board." ~ Warren Buffett ~      ~~~ BULLISH SENTIMENT ESCALATING (danger)... but MCCLELLAN OSCILLATOR IN NEUTRAL, PLUS MORE...

Recently, Optimer Pharmaceuticals, Inc. (OPTR) received a boost when its candidate fidaxomicin, which is being developed for treating adults suffering from clostridium difficile infection (CDI), fared well in late-stage multi-center, randomized, double-blind studies (n=1,164). Results from the...

New York-based outsourcing service provider, Paychex Inc. (PAYX) announced the rollout of a new solution for filling up form 5500. The solution will come in handy for the many organizations offering retirement schemes.   Form 5500 is an annual reporting requirement prescribed under the Internal...

Korn/Ferry International (KFY) swung to a net income of $10.9 million or 24 cents per share in the first quarter of fiscal 2011, from a net loss of $14.3 million or 33 cents per share in the year-ago quarter. Quarterly earnings handily beat the Zacks Consensus Estimate of 20 cents per share. The...

Stephen Bernard, AP Business Writer Stocks continue rally after drop in jobless claims Stocks climb following bigger-than-expected drop in claims for unemployment benefits Stocks extended their September rally Thursday after more encouraging news on the job market. The Dow Jones industrial average...

Deutsche Bank recently lowered its price target to $62 from $65 as well as its EPS estimate $0.02 for Manpower (NYSE: MAN). In Manpower's Global Employment Outlook, the CEO Jeff Joerres implied that demand trends were still very strong. "Clearly there are signs of a softening labor market, but...

Korn/Ferry International (NYSE: KFY) announced Q1 FY'11 diluted earnings per share of $0.24 compared to diluted loss per share of $0.33 in Q1 FY'10. Excluding restructuring charges of $18.2 million, diluted loss per share in Q1 FY'10 was $0.05.